Correct Capital Wealth Management’s AbbVie ABBV Stock Holding History

Correct Capital Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.32M	Sell	9,208 -122	-1%	-$26.2K	0.4%	33
2026 Q1	$2.03M	Sell	9,330 -31	-0.3%	-$6.88K	0.38%	36
2025 Q4	$2.14M	Buy	9,361 +489	+6%	+$111K	0.4%	35
2025 Q3	$2.05M	Buy	8,872 +222	+3%	+$45.2K	0.34%	38
2025 Q2	$1.61M	Buy	8,650 +351	+4%	+$65.2K	0.23%	42
2025 Q1	$1.74M	Buy	8,299 +227	+3%	+$44.1K	0.28%	36
2024 Q4	$1.43M	Buy	8,072 +703	+10%	+$129K	0.29%	38
2024 Q3	$1.46M	Buy	7,369 +1,295	+21%	+$242K	0.32%	39
2024 Q2	$1.04M	Buy	6,074 +663	+12%	+$110K	0.24%	49
2024 Q1	$985K	Buy	5,411 +682	+14%	+$118K	0.23%	55
2023 Q4	$733K	Buy	+4,729	New	+$689K	0.19%	61

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Correct Capital Wealth Management's ABBV Position: Q2 2026 in Review

Correct Capital Wealth Management reduced its AbbVie (ABBV) stake by 1.3% in Q2 2026, selling an estimated $26.2K and leaving 9,208 shares worth $2.32M. The position accounts for 0.4% of the portfolio, ranked #33.

Correct Capital Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Correct Capital Wealth Management held 9,208 shares of AbbVie worth $2.32M as of Q2 2026.
Correct Capital Wealth Management sold 122 AbbVie shares in Q2 2026, an estimated $26.2K.
AbbVie made up 0.4% of Correct Capital Wealth Management's portfolio in Q2 2026, its #33 holding.
Correct Capital Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Correct Capital Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.